Public Schools
Rochester, New York, 14614, United States
NCT Number: NCT07164144
Influenza is associated with millions of cases of school absenteeism due to illness, hundreds of hospitalizations and thousands of deaths in the U.S. each year, which can be greatly reduced with influenza vaccination.
The goal of this randomized controlled trial is to learn if training school personnel in vaccine communication techniques and equipping schools with vaccine promotional materials targeting students and their parents/guardians increases the influenza vaccination rates of the student population within participating schools.
The main question it aims to answer is:
-Will flu vaccination rates be higher in intervention schools compared to control schools by the end of the intervention period?
Participating schools will:
* Have select school personnel (school nurses, coaches, teachers, etc.) complete an online training module and optional training workshop focused on vaccine communication [intervention arm only] * Utilize vaccine promotional materials (posters, flyers, digital files for social media, etc.) provided by the study team during flu season [intervention arm only] * Track student vaccination rates [intervention + control arm]
Interested in participating?
Request Info5 year–21 year
All sexes
Interventional
Not applicable
Rochester, New York, 14614, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
School personnel receive vaccine communication training + promotional materials
Time frame: 8 months (one flu season August-March)
University of Rochester
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04367883
ACE Inhibitors, ARB
Terrassa, Barcelona, Spain
View Trial DetailsNCT07310472
Infections, Influenza Vaccination
Turku, Finland
View Trial DetailsNCT06850051
Healthy Volunteers, Human Metapneumovirus Vaccination
Blacktown, New South Wales, Australia
View Trial DetailsNCT07231016
Communicable Diseases, Disease Attributes
Taipei, Taiwan
View Trial Details